A Jaipur healthtech startup has secured Rs 4 crore in seed funding to push its AI-powered autism screening technology beyond pilot testing and into clinics, schools, and government health centers nationwide. Aignosis plans to use the capital to scale what it describes as a distribution-first approach to developmental screening, one that starts in small public facilities rather than metro hospitals.
Antler and Nikhil Kamath led the round. Varun Dua and IIMA Ventures also participated. This capital injection arrives as India grapples with a severe shortage of child development specialists. Early detection remains rare outside major cities. Consequently, many children miss critical intervention windows.
Founded by Raksheet Jain and Divyansh Mangal, Aignosis previously raised an initial round in 2024 from investors including Rajneesh Bhandari and Amit Jain. The startup developed a screening system that works with a standard laptop and webcam. Children aged 16 months to nine years watch nine short stimulus videos. Computer vision then tracks gaze patterns, name responses, and facial expression reactions. The software produces a risk report indicating whether further clinical assessment seems warranted. It does not diagnose.
Regulatory clearance came from India’s Central Drugs Standard Control Organisation, which granted Class B certification. Incubation support came from IIMA Ventures. Google selected Aignosis for its 2025 AI First accelerator program, choosing the startup from over 1,600 applicants.
The company runs what it calls a Clinic-in-Clinic model. Rather than selling standalone devices, Aignosis embeds screening within pediatric practices. Over 20 government primary health centers in Rajasthan currently use the system. A partnership with Mankind Pharma sends medical representatives to support screening camps with pediatricians across India. Meanwhile, operations with Apollo SHINE Foundation will reach roughly 125 schools.
Having completed more than 8,000 screenings so far, Aignosis targets 100,000 by the end of FY2026-27. Expansion plans cover Punjab, the National Capital Region, Haryana, Tamil Nadu, Jharkhand, Karnataka, and Maharashtra. The Rajasthan deployment serves as a template for broader government adoption. As a result, the company expects its technology to reshape how early developmental screening reaches children outside India’s largest cities.
